EP2646003

ADARE PHARMACEUTICALS
Application Number
EP11845725A
Filing Date
Dec 2, 2011
Status
Revoked
Nov 19, 2021
Grant Date
Jun 3, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Bibliography

The patent EP2646003B1 was granted to Adare Pharmaceuticals on Jun 3, 2020 following the initial filing on Dec 2, 2011 under the application number EP11845725A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

DR FALK PHARMAFeb 23, 2021 -

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents